Clinical Trial Update: Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares Ulipristal acetate to a GnRH analogue to assess myometrial preservation in women with uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Esmya (ulipristal acetate)
• Leuprolide acetate (Leuprolide acetate)

Snippet

Sponsor: University Magna Graecia | Conditions: Fibroid | Phase 4 | Status: UNKNOWN